Hemispherx Biopharma Board Appoints New President
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- Wall Street mixed as Moderna rallies and chips tumble
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.04/Share
August 13, 2015 9:02 AM EDTHemispherx Biopharma (NYSE: HEB) reported Q2 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
... More